{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:11:17Z","timestamp":1792782677455,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-A-192"],"award-info":[{"award-number":["2022-PUMCH-A-192"]}]},{"name":"the CAMS Innovation Fund for Medical Sciences","award":["2021-12M-C&T-B-005"],"award-info":[{"award-number":["2021-12M-C&T-B-005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s00277-023-05525-7","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T22:02:01Z","timestamp":1699308121000},"page":"545-552","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Distinct FDG PET\/CT avidity among newly diagnosed intravascular large B-cell lymphoma patients: a descriptive observational study"],"prefix":"10.1007","volume":"103","author":[{"given":"Danqing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daobin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9489-5965","authenticated-orcid":false,"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,7]]},"reference":[{"issue":"9","key":"5525_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10428194.2017.1287363","volume":"58","author":"DJ Rajyaguru","year":"2017","unstructured":"Rajyaguru DJ, Bhaskar C, Borgert AJ, Smith A, Parsons B (2017) Intravascular large B-cell lymphoma in the United States (US): a population-based study using Surveillance, Epidemiology, and End Results program and National Cancer Database. Leuk Lymphoma 58(9):1\u20139. https:\/\/doi.org\/10.1080\/10428194.2017.1287363","journal-title":"Leuk Lymphoma"},{"issue":"15","key":"5525_CR2","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1182\/blood-2017-04-737445","volume":"132","author":"M Ponzoni","year":"2018","unstructured":"Ponzoni M, Campo E, Nakamura S (2018) Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks. Blood 132(15):1561\u20131567. https:\/\/doi.org\/10.1182\/blood-2017-04-737445","journal-title":"Blood"},{"key":"5525_CR3","unstructured":"Campo E, Harris NL, Pileri SA, Jaffe ES, Stein H, Thiele J (n.d.) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC Who Classification of Tum"},{"issue":"2","key":"5525_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/bjh.15923","volume":"186","author":"M Geer","year":"2019","unstructured":"Geer M, Roberts E, Shango M, Till BG, Smith SD, Abbas H, Hill BT, Kaplan J, Barr PM, Caimi P, Stephens DM, Lin E, Herrera AF, Rosenbaum E, Amengual JE, Boonstra PS, Devata S, Wilcox RA, Kaminski MS, Phillips TJ (2019) Multicentre retrospective study of intravascular large B-cell lymphoma treated at academic institutions within the United States. Br J Haematol 186(2):255\u2013262. https:\/\/doi.org\/10.1111\/bjh.15923","journal-title":"Br J Haematol"},{"key":"5525_CR5","doi-asserted-by":"crossref","unstructured":"Podoloff DA, Advani RH, Allred C, 3rd Benson AB, Brown E, Burstein HJ, Carlson RW, Coleman RE, Czuczman MS, Delbeke D, Edge SB, Ettinger DS, Jr Grannis FW, Hillner BE, Hoffman JM, Kiel K, Komaki R, Larson SM, Mankoff DA, Rosenzweig KE, Skibber JM, Yahalom J, Yu JM, Zelenetz AD (2007) NCCN task force report: positron emission tomography (PET)\/computed tomography (CT) scanning in cancer. J Natl Compr Canc Netw 5 Suppl 1:S1\u201322; quiz S23\u201322","DOI":"10.6004\/jnccn.2007.2001"},{"issue":"6","key":"5525_CR6","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1007\/s00259-010-1713-9","volume":"38","author":"TC Kwee","year":"2011","unstructured":"Kwee TC, Basu S, Saboury B, Ambrosini V, Torigian DA, Alavi A (2011) A new dimension of FDG-PET interpretation: assessment of tumor biology. Eur J Nucl Med Mol Imaging 38(6):1158\u20131170. https:\/\/doi.org\/10.1007\/s00259-010-1713-9","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5525_CR7","doi-asserted-by":"publisher","first-page":"7289","DOI":"10.2147\/CMAR.S330308","volume":"13","author":"CH Lim","year":"2021","unstructured":"Lim CH, Yoon SE, Kim WS, Lee KH, Kim SJ (2021) Imaging features and prognostic value of FDG PET\/CT in patients with intravascular large B-cell lymphoma. Cancer Manag Res 13:7289\u20137297. https:\/\/doi.org\/10.2147\/CMAR.S330308","journal-title":"Cancer Manag Res"},{"issue":"19","key":"5525_CR8","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1200\/JCO.2007.15.4278","volume":"26","author":"K Shimada","year":"2008","unstructured":"Shimada K, Matsue K, Yamamoto K, Murase T, Ichikawa N, Okamoto M, Niitsu N, Kosugi H, Tsukamoto N, Miwa H, Asaoku H, Kikuchi A, Matsumoto M, Saburi Y, Masaki Y, Yamaguchi M, Nakamura S, Naoe T, Kinoshita T (2008) Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan. J Clin Oncol 26(19):3189\u20133195. https:\/\/doi.org\/10.1200\/JCO.2007.15.4278","journal-title":"J Clin Oncol"},{"issue":"4","key":"5525_CR9","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S1470-2045(20)30059-0","volume":"21","author":"K Shimada","year":"2020","unstructured":"Shimada K, Yamaguchi M, Atsuta Y, Matsue K, Sato K, Kusumoto S, Nagai H, Takizawa J, Fukuhara N, Nagafuji K, Miyazaki K, Ohtsuka E, Okamoto M, Sugita Y, Uchida T, Kayukawa S, Wake A, Ennishi D, Kondo Y, Izumi T, Kin Y, Tsukasaki K, Hashimoto D, Yuge M, Yanagisawa A, Kuwatsuka Y, Shimada S, Masaki Y, Niitsu N, Kiyoi H, Suzuki R, Tokunaga T, Nakamura S, Kinoshita T (2020) Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial. Lancet Oncol 21(4):593\u2013602. https:\/\/doi.org\/10.1016\/S1470-2045(20)30059-0","journal-title":"Lancet Oncol"},{"issue":"4","key":"5525_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.blre.2016.02.003","volume":"30","author":"L Valls","year":"2016","unstructured":"Valls L, Badve C, Avril S, Herrmann K, Faulhaber P, O\u2019Donnell J, Avril N (2016) FDG-PET imaging in hematological malignancies. Blood Rev 30(4):317\u2013331. https:\/\/doi.org\/10.1016\/j.blre.2016.02.003","journal-title":"Blood Rev"},{"issue":"1","key":"5525_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2967\/jnumed.109.067892","volume":"51","author":"M Weiler-Sagie","year":"2010","unstructured":"Weiler-Sagie M, Bushelev O, Epelbaum R, Dann EJ, Haim N, Avivi I, Ben-Barak A, Ben-Arie Y, Bar-Shalom R, Israel O (2010) (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients. J Nucl Med 51(1):25\u201330. https:\/\/doi.org\/10.2967\/jnumed.109.067892","journal-title":"J Nucl Med"},{"issue":"21","key":"5525_CR12","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1200\/JCO.2005.12.072","volume":"23","author":"H Schoder","year":"2005","unstructured":"Schoder H, Noy A, Gonen M, Weng L, Green D, Erdi YE, Larson SM, Yeung HW (2005) Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin\u2019s lymphoma. J Clin Oncol 23(21):4643\u20134651. https:\/\/doi.org\/10.1200\/JCO.2005.12.072","journal-title":"J Clin Oncol"},{"issue":"5","key":"5525_CR13","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00428-019-02698-3","volume":"476","author":"RL King","year":"2020","unstructured":"King RL, Goodlad JR, Calaminici M, Dotlic S, Montes-Moreno S, Oschlies I, Ponzoni M, Traverse-Glehen A, Ott G, Ferry JA (2020) Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis. Virchows Arch 476(5):647\u2013665. https:\/\/doi.org\/10.1007\/s00428-019-02698-3","journal-title":"Virchows Arch"},{"issue":"8","key":"5525_CR14","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.7150\/thno.54343","volume":"11","author":"M Alame","year":"2021","unstructured":"Alame M, Cornillot E, Cacheux V, Rigau V, Costes-Martineau V, Lacheretz-Szablewski V, Colinge J (2021) The immune contexture of primary central nervous system diffuse large B cell lymphoma associates with patient survival and specific cell signaling. Theranostics 11(8):3565\u20133579. https:\/\/doi.org\/10.7150\/thno.54343","journal-title":"Theranostics"},{"key":"5525_CR15","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1038\/bcj.2013.28","volume":"3","author":"W Kraan","year":"2013","unstructured":"Kraan W, Horlings HM, van Keimpema M, Schilder-Tol EJ, Oud ME, Scheepstra C, Kluin PM, Kersten MJ, Spaargaren M, Pals ST (2013) High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites. Blood Cancer J 3:e139. https:\/\/doi.org\/10.1038\/bcj.2013.28","journal-title":"Blood Cancer J"},{"issue":"18","key":"5525_CR16","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1182\/blood-2017-12-822817","volume":"131","author":"AMR Schrader","year":"2018","unstructured":"Schrader AMR, Jansen PM, Willemze R, Vermeer MH, Cleton-Jansen AM, Somers SF, Veelken H, van Eijk R, Kraan W, Kersten MJ, van den Brand M, Stevens WBC, de Jong D, Abdul Hamid M, Tanis BC, Posthuma EFM, Nijland M, Diepstra A, Pals ST, Cleven AHG, Vermaat JSP (2018) High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma. Blood 131(18):2086\u20132089. https:\/\/doi.org\/10.1182\/blood-2017-12-822817","journal-title":"Blood"},{"issue":"2","key":"5525_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1148\/radiol.2312021185","volume":"231","author":"EM Rohren","year":"2004","unstructured":"Rohren EM, Turkington TG, Coleman RE (2004) Clinical applications of PET in oncology. Radiology 231(2):305\u2013332. https:\/\/doi.org\/10.1148\/radiol.2312021185","journal-title":"Radiology"},{"issue":"Suppl 2","key":"5525_CR18","doi-asserted-by":"publisher","first-page":"24S","DOI":"10.2967\/jnumed.107.047258","volume":"49","author":"RJ Gillies","year":"2008","unstructured":"Gillies RJ, Robey I, Gatenby RA (2008) Causes and consequences of increased glucose metabolism of cancers. J Nucl Med 49(Suppl 2):24S-42S. https:\/\/doi.org\/10.2967\/jnumed.107.047258","journal-title":"J Nucl Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05525-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05525-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05525-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T02:04:47Z","timestamp":1705629887000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05525-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,7]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["5525"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05525-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,7]]},"assertion":[{"value":"14 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was waived by the local Ethics Committee of Peking Union Medical College Hospital in view of the retrospective nature of the study, and all the procedures being performed were part of the routine care. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}